基石藥業-B(02616.HK)向首席執行官楊建新博士授出2800萬份購股權

You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.

Hong Kong

Open Account

基石藥業-B(02616.HK)向首席執行官楊建新博士授出2800萬份購股權

格隆匯 08-30 20:56

格隆匯8月30日丨基石藥業-B(02616.HK)公告，於2022年8月30日，公司根據首次公開發售後僱員持股計劃的條款向首席執行官兼執行董事楊建新博士授出2800萬份購股權，所授出購股權的認購價每股股份4.660港元。

基石药业-B(02616.HK)

Relevant Stocks

基石药业-B(02616.HK)

Customer Service Hotline︰+852 3018 4526

Email︰cs@usmarthk.com

Address︰26/F, 2606, 308 Des Voeux Road Central, Sheung Wan, Hong Kong

WhatsApp︰+852 5989 2641

Join the Community：

uSmart Securities Limited

is a licensed corporation approved by the Hong Kong SFC (CE number: BJA907), provides securities trading services and is subject to its supervision.

Market News

基石藥業-B(02616.HK)向首席執行官楊建新博士授出2800萬份購股權

Services

About Us

Agreement Statement